Osteoporosis Canada

Tag: Highlighted

PHAC Osteoporosis Key Findings

Osteoporosis Canada has been working closely with the Public Health Agency of Canada (PHAC) over the past few years assisting in the collection of data in Canada’s Canadian Chronic Disease Surveillance System (CCDSS).

The following infographic Osteoporosis and related fractures in Canada, 2021 is based on the most recent CCDSS data and provides an update on key findings from PHAC’s 2020 Report. It is just one outcome in the last decade resulting from Osteoporosis Canada working in partnership with PHAC.

The infographic provides an update on key findings from PHAC’s 2020 report Osteoporosis and related fractures in Canada: Report from the Canadian Chronic Disease Surveillance System (CCDSS) 2020 using the most recent data available in the CCDSS.


Jack Hirsh Award Recipient

Jack Hirsh Award

Rick Adachi MD, FRCPC

The McMaster Academic and Education Department of Medicine Awards review committee have selected an outstanding group of individuals for the 2020-2021 academic year.

Past Osteoporosis Canada Scientific Advisory Council Member, Dr. Rick Adachi is the winner of the Jack Hirsh Award. This is the preeminent achievement award given by the McMaster Department of Medicine.

The award is given annually to a full-time member of the McMaster community with a primary or secondary appointment in medicine. Dr Adachi is retiring this year and this award is fitting recognition of his contributions to the Department.

Congratulations Dr. Adachi!


Canadian Fracture Liaison Services Join the Capture the Fracture® Map of Best Practice

Media Release

Osteoporosis Canada and the International Osteoporosis Foundation underline their shared goal of improving clinical outcomes and preventing recurrent fractures in patients who have sustained fractures due to osteoporosis.

Today, the International Osteoporosis Foundation (IOF) and Osteoporosis Canada (OC) are pleased to announce the inclusion of 42 Fracture Liaison Services (FLS) from the Osteoporosis Canada FLS Registry on the Capture the Fracture® Map of Best Practice.

The integration of the Canadian FLS on the Capture the Fracture® global map follows a collaboration agreement in which the two organizations underline their shared goal of improving clinical outcomes and preventing recurrent fractures in patients who have sustained fractures due to osteoporosis.

Worldwide, approximately 80% of patients who have already sustained an osteoporosis-related fracture do not receive the care they need to prevent further costly, and often severely debilitating, fragility fractures. Fracture Liaison Services (FLS) represent the most effective strategy to tackle this enormous care gap. In an FLS, a multidisciplinary care team, with the help of a dedicated FLS coordinator, ensures that patients are identified, treated and monitored following a fracture. This results in fewer re-fractures and lower mortality rates, while reducing future costs due to hospital admissions, operations and care home admissions.

IOF CEO, Philippe Halbout, stated:

“The IOF Capture the Fracture® program, a global platform for FLS recognition, sustainability and development, is immensely pleased to welcome the Canadian FLS to its Map of Best Practice, which now provides visibility and recognition for 623 programs in 48 countries worldwide. We thank Osteoporosis Canada for their important collaboration and ongoing support as this will serve to strengthen the global outreach and impact of the CTF program.”

Osteoporosis Canada has been a pioneer in FLS implementation and in setting quality standards for FLS services. The Canadian Fracture Liaison Services which are newly included in the CTF Map of Best Practice have all met the high standards of Osteoporosis Canada’s FLS Registry.

Osteoporosis Canada President and CEO Dr Famida Jiwa added:

“A recent report by the Public Health Agency of Canada (2020) has documented the huge post-fracture care gap that still exists in Canada: less than 20% of patients who fracture receive an osteoporosis intervention. Osteoporosis Canada supports the implementation of FLS as it is the most effective route to closing this care gap. There are currently 42 FLSs on the OC FLS Registry and we are pleased to see them showcased on the IOF Capture the Fracture® Map of Best Practice.”


For More Information:
Tracie Napoli
Director, Fund Development & MARCOM
Osteoporosis Canada
416-696-2663 / 1-800-463-6842 ext. 2286

About IOF

The International Osteoporosis Foundation (IOF) is the world’s largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 266 patient, medical and research societies, work together to make fracture prevention and healthy mobility a worldwide health care priority. https://www.osteoporosis.foundation

Visit the IOF website

About Capture the Fracture®

Capture the Fracture® (CTF) is a multi-stakeholder initiative led by the International Osteoporosis Foundation (IOF). The initiative hopes to drive changes at local and international levels, so that secondary fracture prevention becomes a reality. Its aim is to set global best practices for Fracture Liaison Services (FLS), while serving as a benchmark tool to which clinics and hospitals can adhere and aspire to, and receive international recognition. The CTF programme has a diverse set of tools that provides essential resources and documentation to drive quality improvement in FLS; CTF also offers mentorship programmes that support development of FLS at the local level. Currently the CTF network includes 623 FLS from 48 countries worldwide. https://www.capturethefracture.org #CaptureTheFracture

Visit the Capture the Fracture website

About Osteoporosis Canada

Osteoporosis Canada (OC) is the only national Canadian organization serving people who have, or are at risk for, osteoporosis. The organization works to educate, empower and support individuals and communities in bone health and in the risk-reduction and treatment of osteoporosis. OC was the world’s first organization dedicated to osteoporosis, the first to establish guidelines for long-term treatment and exercise, and the first to introduce fracture risk assessment. Over a decade ago, OC began to focus on secondary fracture prevention and has created numerous tools to support Fracture Liaison Service (FLS) implementation, including its FLS Toolkit. https://osteoporosis.ca/

Visit the Osteoporosis Canada website

About Osteoporosis Canada’s FLS Hub:

OC’s FLS Hub (website) was launched in 2013 to provide multiple practical tools and resources to support and facilitate the implementation of FLSs throughout Canada. OC’s National FLS Team assists FLS teams across the country, whether they are in their pre- or post-implementation stages. To recognize successful FLSs, OC launched its FLS Registry in 2016. It showcases FLSs which meet all of OC’s Essential Elements of FLS. The FLS Registry currently lists 42 Canadian FLSs. In 2017, to assist with the FLSs’ ongoing quality improvement efforts, OC conducted the country’s first national FLS audit. A second national FLS audit was completed in the fall of 2020. Compared to the first audit, the 2020 audit demonstrated an overall improvement in all of OC’s core FLS Key Performance Indicators. https://fls.osteoporosis.ca

Visit the Osteoporosis Canada FLS Hub website


Tribute to Dr. Harry Genant

HARRY K. GENANT, MD (1942-2021)

Osteoporosis Canada is saddened to announce the passing of Dr. Harry K. Genant, internationally renowned for his ground-breaking research in non-invasive and quantitative imaging methods for osteoporosis, arthritis and orthopedics.

The Osteoporosis Canada family extends its heartfelt condolences to the family and friends of the late Dr. Genant.

You can view the tribute for Harry K. Genant, MD from the University of California, San Francisco Department of Radiology & Biomedical Imaging here.


CIHR Institute of the Musculoskeletal Health and Arthritis Advisory Board

Dr. Suzanne Morin

Dr. Suzanne Morin has been named a member of the Canadian Institutes of Health Research (CIHR) Institute of the Musculoskeletal Health and Arthritis Advisory Board.

In this capacity Dr. Morin will participate in discussions, research priority setting and strategic planning to promote Musculoskeletal health for Canadians.

Dr. Morin is the Associate Professor in the Department of Medicine, member of the divisions of General Internal Medicine, Endocrinology and Clinical Epidemiology and scientist at the Centre for Outcomes Research and Evaluation of the Research Institute of the McGill University Health Center. She is co-director of the Clinical Scholar Program for the General Internal Medicine training program and is a member of Osteoporosis Canada’s Scientific Advisory Council (SAC).

The CIHR is Canada’s federal funding agency for health research. Composed of 13 Institutes, the CIHR collaborates with partners and researchers to support the discoveries and innovations that improve our health and strengthen the Canadian health care system.

Congratulations to Dr. Morin!


The Public Health Agency of Canada (PHAC) releases its anticipated new report: “Osteoporosis and related fractures in Canada”

Osteoporosis and Related Fractures in Canada

This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older.  It reports on administrative data from the Canadian Chronic Disease Surveillance System (CCDSS), including trend data spanning a surveillance period of 15 years, from 2000-2001 to 2015-2016.  

Here are some important excerpts from the PHAC report:

  • “the absolute number of fractures of the forearm, hip, spine, humerus and pelvis increased over the 15-year surveillance period (from 95,000 in 2000-2001 to 132,000 in 2015-2016)”.  Go to page 35.
  • “Almost one-quarter (227.5 per 1,000 or 22.8%) of those who fractured a hip in 2014-2015 died of any cause within the following 12 months.”  Go to page 36.
  • “While women were 2 times more likely to fracture their hip, men were 1.3 times more likely to die of any cause within 12 months following their hip fracture.”  Go to page 36.
  • “A key finding of this report is that despite well-established clinical practice guidelines and initiatives to promote osteoporosis care, screening and treatment initiation rates following a fracture remain very low in Canada.”  Go to page 53.
  • “Within one year of fracture, less than 20% received an osteoporosis diagnosis, underwent a BMD test or received a prescription for an osteoporosis-related medication.”  Go to page 39.
  • “Irrespective of fracture site, men were less likely to receive a prescription than women.”  Go to page 44.
  • “Given the success of secondary fracture prevention and the resulting cost-saving benefits, increasing accessibility to FLS across the country may help to close the existing osteoporosis care gap.”  Go to page 46.

We urge you to read this very compelling and fact-based report regarding the state of osteoporosis care for Canadians who suffer a fracture.  It is available here.

The report is also available in French here.



Dr. Earl Bogoch


TORONTO, November 19, 2020 – Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention.

Dr. Famida Jiwa, President & CEO, Osteoporosis Canada is pleased to announce that Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention.  This University of Toronto chair, a global first of its type, has been established at the University of Toronto and St. Michael’s Foundation through the generosity of Brookfield Partners Foundation, which provided a $3 million grant.  Dr. Bogoch was appointed after a Faculty search process.

“This is truly a ground-breaking milestone for osteoporosis diagnosis and fracture prevention care in Canada,” said Dr. Famida Jiwa. “Working in collaboration with our partners and Dr. Bogoch we are certain that our organization’s vision of a Canada free of osteoporotic fractures is possible.”

Dr. Bogoch, an orthopaedic surgeon at St. Michael’s Hospital and Professor in the Department of Surgery, said: “The new Brookfield Chair provides an exciting avenue to advance fracture prevention programs into the 7 provinces and 3 territories in Canada where none yet exist.  Every year 130,000 Canadians sustain serious fragility fractures, including 30,000 hip fractures and only 20% of them receive the necessary treatment they need to prevent the next catastrophic fracture.   I am honoured to be appointed The Brookfield Chair in Fracture Prevention, and excited to enhance our partnership with Osteoporosis Canada to fulfil their mission statement of preventing hip fractures in Canada.”

Dr. Bogoch, a Canadian and world pioneer in fracture prevention, initiated his fracture prevention activities at Wellesley Hospital, Toronto, in 1995, based on a realization that older patients treated in his fracture clinic for fragility fractures were at high risk of future devastating hip fractures, and should receive preventive interventions.  After initial studies and early publications describing the care gap, he initiated a comprehensive fracture liaison program in 2002, in collaboration with scientists and clinical colleagues at St. Michael’s Hospital.  After obtaining support from the Ontario Ministry of Health and Long-term Care in 2006 he assisted OC and other stakeholders establish a province-wide Fracture Clinic Screening and Prevention Program, which now operates in 36 hospitals in Ontario and has intervened with over 100,000 patients. 

With Dr. Joanna Sale, he co-leads an MOHLTC-funded research and evaluation group that monitors this program which is headed by Mr. Ravi Jain at OC, for iterative improvements. The programs he and his collaborators lead have won national and international awards. Dr. Bogoch has been awarded the Presidential Award of Merit for Outstanding Contributions from the Canadian Orthopaedic Association for his work in fracture prevention, and he has published 80 peer-reviewed publications in the field, many of them highly cited.  Dr. Bogoch has been an active member of Osteoporosis Canada’s Scientific Advisory Council serving on its many committees including the executive committee and most recently its development committee.  In 2013, Dr. Bogoch was awarded the Lindy Fraser Award as chosen by his peers.

In an interview, Dr. Bogoch expressed enthusiasm for the novel role of a Chair in Fracture Prevention.  “The establishment of a world first university chair is overdue – it will confirm the evolution of fracture prevention beyond program development into an academic subject in its own right.  We will establish graduate scholarships to promote the work of young scientists in improving health service delivery and to design the fracture prevention programs of tomorrow.  The Chair will collaborate with Osteoporosis Canada and local experts to promote and fund the establishment of fracture liaison programs in jurisdictions that are lagging behind the three Canadian provinces who now have functioning programs.  The resources of the Chair will also enable enhancement of the research work my collaborators and I are doing in iteratively improving how we do fracture prevention, how we inform people at risk how to protect themselves, and augmenting our information sharing with colleagues in Canada and around the world.”

Tracie Napoli
Director, Fund Development & MARCOM
Osteoporosis Canada
416-696-2663 / 1-800-463-6842 ext. 2286


Osteoporosis Canada is the only national organization serving people affected by osteoporosis. The organization works to educate, empower and support individuals and communities on bone health and in the risk-reduction and treatment of osteoporosis.

Commonly referred to as the “silent thief,” osteoporosis is an incurable disease that can cause bones to weaken over time, without any signs or symptoms leading to increased risk of breaking a bone.

Osteoporosis Canada provides medically accurate information to patients, health care professionals and the public. The organization has established clinical practice guidelines and long-term care and exercise recommendations. The Scientific Advisory Council (SAC) is made up of experts in osteoporosis and bone metabolism and is a volunteer membership. Comprised of clinicians, researchers and educators, the SAC advises Osteoporosis Canada’s board and staff on scientific and medical issues.




The International Society for Clinical Densitometry (ISCD) Researcher of the Year award for 2020 was recently presented to Dr. William D. Leslie, MD, FRCPC, MSc, CCD.

This award is given to an outstanding researcher for distinguished service to the field of densitometry in the areas of publication, education, or leadership. Awardees are nominated by their peers and colleagues in the field for their outstanding contributions to the field of densitometry.

Dr. Leslie is a Professor of Medicine and Radiology at the University of Manitoba with over 450 peer-reviewed publications. His research interests are in fracture risk assessment, osteoporosis testing, and other nuclear diagnostic techniques. He is Past President of the International Society for Clinical Densitometry, Past Chair of the Osteoporosis Canada Scientific Advisory Council, co-led the “2010 Clinical Practice Guidelines in Osteoporosis”, Director of the Manitoba Bone Density Program, and Co-Director of the Winnipeg PET Imaging Centre. He is currently the co-chair of the Osteoporosis Canada’s 2020 Clinical Practice Guidelines Steering Committee.

Congratulations Bill!


Tribute to Dr. Timothy Murray 1938-2019

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada.

Dr. Murray was the Emeritus Professor of Medicine at the University of Toronto, past Director of the Toronto CaMos Centre and past Director of the Metabolic Bone Clinic at St. Michael’s Hospital, Toronto. He played an active role in the American Society of Bone and Mineral Research and the International Society of Clinical Densitometry. He was awarded the Order of Canada in 2007 for his significant contributions to osteoporosis research and education in Canada.

Without Dr. Murray, Osteoporosis Canada would not be the organization it is today.

Through the 1970’s, Dr. Murray was a physician scientist at St. Michael’s Hospital in Toronto researching fundamental bone science. He started the first Metabolic Bone Clinic in Canada at St. Michael’s Hospital in 1981 bringing together people who were already suffering from the acute pain and deformity of osteoporosis, mostly elderly women. During this time the treatment and care for patients was still undeveloped. Dr. Murray’s team worked to develop the medical procedures and facilities together with patients who were also passionately motivated to support the cause.

These patients were women who were extremely determined despite their burden of pain. They were convinced that through their efforts and initiative they could affect change. They supported the physicians and researchers by drawing public awareness to the ravages of the disease, by raising money for research and by supporting each other. Ultimately, this group of women formed an army of volunteers across the country – strong and committed. Some of the key people were Eleanor Mills and Lindy Fraser.

Volunteers convinced newspaper columnists to take their osteoporosis story to the general public. Before long, eye catching headlines appeared such as Silent Thief will Rob Our Bones of Calcium, Fighting Back: A walk for all of Canada and Wealthy Women Should do More to Support Research. In the latter article, Dr. Murray was asked why osteoporosis had received so little attention. He responded, “It gets overlooked because of ageism and sexism.”  In response the writer worte, “I was startled. Dr. Murray sounds like a conscious scientific type, not the sort given to the lingo of social change.”

During this time, Dr. Murray together with Dr. Joan Harrison and his clinic staff were thinking about how they could maximize their efforts. One morning Dr. Murray boarded the bus on the way to work and got into a conversation with a new neighbor – a lawyer named Michael Slant. When Dr. Murray told him of his involvement in the field of osteoporosis, Mr. Slant said he immediately knew what Dr. Murray was talking about and he expressed interest. Dr. Murray further shared the difficulties of finding funding for research. Mr. Slant immediately said a society was needed.

As a result of the chance meeting between these two gentleman, the process began to form The Osteoporosis Society of Canada. The work to create the society was done in Dr. Murray’s living room and in October 1982 The Osteoporosis Society of Canada ultimately received its charitable status.

Since 1982, Osteoporosis Canada – the current name of the organization, has grown exponentially and made a significant impact in the areas of bone health and osteoporosis largely due to Dr. Murray. Given the groundbreaking work done in Canada, Dr. Murray who also was asked to consult on the formation of an osteoporosis organization in the United States. And before long, similar organizations started appearing in other countries.

Led by the passion and commitment of Dr. Murray, Dr. Joan Harrison and others, Canadians initiated an international movement in osteoporosis. It was a model of which we can all be proud.

The Osteoporosis Canada family extends it heartfelt condolences to Dr. Murray’s wife Joan, their children Peter and Laura; grandchildren Joe and Clara and their entire family.

You can view the obituary for Timothy MacLeod Murray M.D. here


It is with great sadness but with pride and nostalgic remembrance that I write a few words about Dr Timothy Murray (emeritus professor of medicine) who passed away on August 27. He was my mentor and subsequently my professional colleague and friend for over 30 years. He played a pivotal role in endocrinology and metabolism (E&M) in Toronto and indeed in Canada especially in his chosen area in endocrinology of metabolic bone disease and calcium metabolism.

His research ability and expertise was initially developed at the Massachusetts General Hospital where later he was a visiting scientist both there and at the NIH. He developed an early radioimmunoassay for PTH and his laboratory at the University of Toronto focused on studies on PTH action, on intestinal calcium binding protein, on hormone receptor expression and on osteoblast cell function.

At the clinical level, at St Michael’s Hospital (where he was head of the division of E&M) he was involved in clinical drug trials in osteoporosis. He was one of the founding directors (Toronto site) of the Canadian Multicentre Osteoporosis Study (CaMos). In both areas of research (basic and clinical) he was a pioneer in Canada. He had a very productive, noteworthy and illustrious career.

He was also a very accomplished clinician and teacher and developed the first osteoporosis clinic in Canada. He was the founding director of the Bone and Mineral group at the University of Toronto through which a generation of scientists, clinicians and osteoporosis specialists were trained.
He played a leading role in patient advocacy for osteoporosis and together with Dr. Joan Harrison founded the Osteoporosis Society of Canada (now Osteoporosis Canada) in 1981. He was instrumental in seeing it grow and flourish in leadership positions for many years.

He was an exemplar for the younger generation of physicians and scientists to emulate. He had broad interests outside medicine. He was a talented pianist both jazz and classical. He once told me he helped work his way through medical school playing the piano with Grays anatomy on his lap.

He had many friends in Canada and abroad and will be missed but well remembered as a man of integrity, charm and humor who was so accomplished and such a gentleman.

– Robert G. Josse, MD, FRCP, FRCPC, FACP, FACE University of Toronto

Very saddened to hear about the passing of Tim Murray.

Tim was a research “renaissance” man having made very significant contributions to basic science, particularly in the area of parathyroid hormone, and then, equally significant contributions to clinical research, especially in the area of osteoporosis. He was also a fine clinician, a real gentleman, and a passionate musician.

Tim touched many people who are better for having known him and experienced his friendship. His passing has increased the void in the type of clinician scientist he represented.

He will certainly be missed.

– David Goltzman, MD, FRCPC McGill University

Like all of us, I’m very sad to hear the news of Tim’s passing. As Dr. Goltzman points out, Tim excelled as a dedicated scientist, teacher, and clinician, and was an even finer person.

I first met Tim when I was an MRC research fellow working on parathyroid hormone in Chicago, and he has been a mentor and friend ever since I returned to Canada. As the first Chair of the Medical Advisory Board of the Osteoporosis Society of Canada, he invited me to join in 1983. He organized and chaired the Osteoporosis Society of Canada’s first national consensus conference on osteoporosis, and these conferences evolved into the Osteoporosis Canada Guidelines, the 4th iteration of which are now being prepared.

His musical skills were amazing, and one of my great regrets was never getting to hear the Tim Murray Jazz Quintet in concert. At the meeting to initiate the Canadian Multicentre Osteoporosis Study (CaMOS) held at the Banff Centre in the late 1990’s, we did have the opportunity to observe his virtuosity, albeit on an old, slightly out-of-tune piano.

My condolences to his family.

– David A. Hanley, MD, FRCPC University of Calgary

About Tim Murray.

I have been thinking about Tim recently and wanting to share with him my recent review of progesterone and bone (Climacteric 2018). And now it is too late.

I was a new comer to British Columbia and UBC in the late 1970s, worked with some renal experts here (Drs. Bert Cameron and the Roger Sutton) on bone health issues and became an advisor to O-STOP, the home-grown osteoporosis self-help group. I therefore knew about the first osteoporosis guidelines project in Canada in the 1980s. And I wished I’d been invited.

I later ran into Tim at the American Society for Bone and Mineral Research meeting—I can’t remember where we were, but we chatting in the sun, there was a sudden downpour and we hid under the same tree! I started cautiously telling him about my idea that progesterone was important for women’s bone formation. He was quite clear in rejecting that notion. I felt hurt.

However, after my 1-year observational study was published in the New England Journal of Medicine in 1990 he sought me out. That study, in 66 normally ovulatory, healthy young women observed over one year had cycles that remained regular but for many, ovulation became disturbed. We found that 20% of cancellous spinal BMD change was related to mean luteal phase length.

He contacted me, asking me more about my research. He invited me to the next OC guidelines conference.

I later worked with him in the early years of the Canadian Multicentre Osteoporosis Study (CaMos)—his and my centres had the slowest and most difficult time in recruitment. One year, when we had our annual CaMos Meeting in Banff, on a night after dinner with deep mountain darkness outside we stood around a piano in a lovely light wood hall listening to his amazing keyboards and singing Jerusalem.

Miss you Tim!

– Jerilynn C. Prior, MD, FRCPC University of British Columbia

Very sad news.

Tim was not only a talented scientist and musician but he was an outstanding mentor and gentleman. I remember my first SAC meeting in 1984 when he gave me the opportunity to join the OC circle and his continuous support during my closer involvement with OC.

There are only few people like Tim, that you have the chance to meet and interact with in a lifetime.

– Jacques Brown, MD, FRCPC Université Laval


Breaking the Cycle of Recurrent Fractures: 2019 Implementation Science Team Project Grant Recipient

After rigorous peer review, the Michael Smith Foundation for Health Research (MSFHR) recently awarded the Fraser Health Authority team in British Columbia (BC), a three-year project team grant worth $500,000. The project, titled “Breaking the cycle of recurrent fracture: Scaling up a secondary fracture prevention program in Fraser Health to inform spread across British Columbia”, is co-led by Dr. Sonia Singh (Fraser Health clinician-researcher,) Larry Funnell (Patient partner researcher) and Dr. Tania Bubela (Simon Fraser University, Dean of Health Sciences). This project may well be the tipping point for Fracture Liaison Service (FLS) implementation in BC. This project will explore how the FLS model implemented at the Peace Arch Hospital (White Rock) in Fraser Health can be successfully adapted and scaled-up to other hospital sites within the health authority.

This leading-edge project aligns with the mandate of Osteoporosis Canada in supporting nation-wide implementation of effective secondary fracture prevention. One key expected outcome is to inform an FLS implementation strategy that can be used to spread the FLS model across BC, thereby improving patients’ quality of life after low-trauma fractures and decreasing health care costs related to recurrent fractures. The research findings from this project may result in dramatically improved access to appropriate osteoporosis care for fracture patients in BC and will impact future program planning of secondary fracture prevention across Canada.

Click here to learn more

Fracture Liaison Service, Healthcare Professionals, Highlighted

© Osteoporosis Canada, 2021
Charitable Registration No. 89551 0931 RR 0001